CN115896168A - A method and application of rapidly obtaining and cultivating tobacco nicotine transformed strains - Google Patents
A method and application of rapidly obtaining and cultivating tobacco nicotine transformed strains Download PDFInfo
- Publication number
- CN115896168A CN115896168A CN202310004201.8A CN202310004201A CN115896168A CN 115896168 A CN115896168 A CN 115896168A CN 202310004201 A CN202310004201 A CN 202310004201A CN 115896168 A CN115896168 A CN 115896168A
- Authority
- CN
- China
- Prior art keywords
- nicotine
- ntncp1
- ntncp2
- tobacco
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000002637 Nicotiana tabacum Nutrition 0.000 title claims abstract description 70
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title claims abstract description 59
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title claims abstract description 59
- 229960002715 nicotine Drugs 0.000 title claims abstract description 59
- 241000208125 Nicotiana Species 0.000 title claims abstract description 47
- 238000000034 method Methods 0.000 title claims abstract description 19
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 82
- 108091033409 CRISPR Proteins 0.000 claims abstract description 32
- 238000010354 CRISPR gene editing Methods 0.000 claims abstract description 18
- 239000000463 material Substances 0.000 claims abstract description 17
- 230000009466 transformation Effects 0.000 claims abstract description 13
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 9
- 241000196324 Embryophyta Species 0.000 claims description 50
- 244000061176 Nicotiana tabacum Species 0.000 claims description 23
- 238000001514 detection method Methods 0.000 claims description 20
- 238000006243 chemical reaction Methods 0.000 claims description 19
- 238000011144 upstream manufacturing Methods 0.000 claims description 16
- 229930013930 alkaloid Natural products 0.000 claims description 11
- 108091027544 Subgenomic mRNA Proteins 0.000 claims description 10
- 239000013598 vector Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 8
- 241000589158 Agrobacterium Species 0.000 claims description 7
- 239000013612 plasmid Substances 0.000 claims description 7
- 150000003797 alkaloid derivatives Chemical class 0.000 claims description 6
- 241000588724 Escherichia coli Species 0.000 claims description 5
- 238000000137 annealing Methods 0.000 claims description 5
- 230000001580 bacterial effect Effects 0.000 claims description 5
- 239000013604 expression vector Substances 0.000 claims description 5
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 claims description 5
- 238000003306 harvesting Methods 0.000 claims description 3
- 108091008146 restriction endonucleases Proteins 0.000 claims description 3
- 238000010356 CRISPR-Cas9 genome editing Methods 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 102000003960 Ligases Human genes 0.000 claims description 2
- 108090000364 Ligases Proteins 0.000 claims description 2
- 241000208134 Nicotiana rustica Species 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 238000002791 soaking Methods 0.000 claims 1
- MYKUKUCHPMASKF-UHFFFAOYSA-N Nornicotine Natural products C1CCNC1C1=CC=CN=C1 MYKUKUCHPMASKF-UHFFFAOYSA-N 0.000 abstract description 13
- MYKUKUCHPMASKF-VIFPVBQESA-N (S)-nornicotine Chemical compound C1CCN[C@@H]1C1=CC=CN=C1 MYKUKUCHPMASKF-VIFPVBQESA-N 0.000 abstract description 12
- 238000010362 genome editing Methods 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 3
- 230000006872 improvement Effects 0.000 abstract description 3
- 230000001404 mediated effect Effects 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 238000011160 research Methods 0.000 abstract description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 229930027917 kanamycin Natural products 0.000 description 5
- 229960000318 kanamycin Drugs 0.000 description 5
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 5
- 229930182823 kanamycin A Natural products 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 238000012408 PCR amplification Methods 0.000 description 4
- 238000010802 RNA extraction kit Methods 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 3
- 244000020518 Carthamus tinctorius Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000009418 agronomic effect Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 238000003209 gene knockout Methods 0.000 description 3
- 239000006870 ms-medium Substances 0.000 description 3
- 206010064571 Gene mutation Diseases 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 108020005089 Plant RNA Proteins 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 2
- 229960003669 carbenicillin Drugs 0.000 description 2
- FBOFHVFMPNNIKN-UHFFFAOYSA-N dimethylquinoline Natural products C1=CC=C2N=C(C)C(C)=CC2=C1 FBOFHVFMPNNIKN-UHFFFAOYSA-N 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 238000002098 selective ion monitoring Methods 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- ROFVEXUMMXZLPA-WQPYEJCJSA-N 3,4-dideuterio-2-pyridin-2-ylpyridine Chemical compound [2H]C1=C(C(=NC=C1)C1=NC=CC=C1)[2H] ROFVEXUMMXZLPA-WQPYEJCJSA-N 0.000 description 1
- NOIIUHRQUVNIDD-UHFFFAOYSA-N 3-[[oxo(pyridin-4-yl)methyl]hydrazo]-N-(phenylmethyl)propanamide Chemical compound C=1C=CC=CC=1CNC(=O)CCNNC(=O)C1=CC=NC=C1 NOIIUHRQUVNIDD-UHFFFAOYSA-N 0.000 description 1
- 241000143437 Aciculosporium take Species 0.000 description 1
- SOPPBXUYQGUQHE-JTQLQIEISA-N Anatabine Chemical compound C1C=CCN[C@@H]1C1=CC=CN=C1 SOPPBXUYQGUQHE-JTQLQIEISA-N 0.000 description 1
- SOPPBXUYQGUQHE-UHFFFAOYSA-N Anatabine Natural products C1C=CCNC1C1=CC=CN=C1 SOPPBXUYQGUQHE-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001522633 Betula utilis subsp. albosinensis Species 0.000 description 1
- 239000008830 Carthamus tinctorius Honghua extract Substances 0.000 description 1
- 101000615488 Homo sapiens Methyl-CpG-binding domain protein 2 Proteins 0.000 description 1
- 102100021299 Methyl-CpG-binding domain protein 2 Human genes 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- -1 acyl nornicotine Chemical compound 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000013373 clone screening Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000000752 ionisation method Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- XKABJYQDMJTNGQ-VIFPVBQESA-N n-nitrosonornicotine Chemical compound O=NN1CCC[C@H]1C1=CC=CN=C1 XKABJYQDMJTNGQ-VIFPVBQESA-N 0.000 description 1
- 238000007034 nitrosation reaction Methods 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
技术领域technical field
本发明涉及植物基因工程技术领域,特别涉及一种快速获得栽培烟草烟碱转化株的方法及应用。The invention relates to the technical field of plant genetic engineering, in particular to a method and application for rapidly obtaining cultivated tobacco nicotine transformed strains.
背景技术Background technique
烟草生物碱主要包括烟碱、降烟碱,新烟草碱和假木贼碱4种主要碱,烟草生物碱的组成和含量对烟叶品质和安全性至关重要。烟草烟碱含量一般在94%以上,降烟碱的比例不超过2.5%。在栽培品种的烟株群体中,一些植株会因为基因突变形成烟碱去甲基酶,烟碱在此酶的作用下脱去甲基,形成降烟碱,导致降烟碱含量显著升高,烟碱显著降低。此类植株被称为转化株。降烟碱很容易发生氧化、酰化和亚硝化反应,生成麦斯明、酰基降烟碱和亚硝基降烟碱(NNN),这些物质的形成对烟叶的香吃味和安全性有重要的不利影响。Tobacco alkaloids mainly include nicotine, nornicotine, anatabine and pseudobasine. The composition and content of tobacco alkaloids are crucial to the quality and safety of tobacco leaves. The nicotine content of tobacco is generally above 94%, and the ratio of nornicotine does not exceed 2.5%. In the tobacco plant population of cultivated varieties, some plants will form nicotine demethylase due to gene mutation, and nicotine will be demethylated under the action of this enzyme to form nornicotine, resulting in a significant increase in nornicotine content. Nicotine was significantly reduced. Such plants are called transformants. Nornicotine is prone to oxidation, acylation and nitrosation reactions to produce mesmin, acyl nornicotine and nitroso nornicotine (NNN). The formation of these substances is important for the taste and safety of tobacco leaves. adverse effects.
目前,已经分离和鉴定有CYP82E5v2、CYP82E2、CYP82E10和CYP82E等基因催化烟碱向降烟碱的转化。正常栽培条件下,部分烟株会发生基因突变从而获得烟碱转化株,但是自然突变很难确定其突变基因,且主要农艺性状不发生变化,选育较为困难。At present, genes such as CYP82E5v2, CYP82E2, CYP82E10 and CYP82E have been isolated and identified to catalyze the conversion of nicotine to nornicotine. Under normal cultivation conditions, some tobacco plants will undergo gene mutations to obtain nicotine transformed strains, but natural mutations are difficult to determine the mutant genes, and the main agronomic traits do not change, making selection and breeding difficult.
发明内容Contents of the invention
本发明所要解决的技术问题是提供一种快速获得栽培烟草烟碱转化株的方法及应用,其为研究烟草烟碱转化基因功能及栽培烟草品种定向改良提供了理论基础。The technical problem to be solved by the present invention is to provide a method and application for rapidly obtaining cultivated tobacco nicotine transformed strains, which provide a theoretical basis for studying the function of tobacco nicotine transformed genes and directional improvement of cultivated tobacco varieties.
本发明所要解决的技术问题是通过以下技术方案来实现的:The technical problem to be solved by the present invention is achieved through the following technical solutions:
一种快速获得栽培烟草烟碱转化株的方法,所述方法是利用CRISPR/Cas9系统同时敲除烟草烟碱转化相关的基因,所述基因为NtNCP1和NtNCP2基因,所述NtNCP1基因序列为SEQ ID No.1所示,所述NtNCP2基因序列为SEQ ID No.3所示。A method for rapidly obtaining and cultivating tobacco nicotine transformed strains, the method is to utilize the CRISPR/Cas9 system to simultaneously knock out genes related to tobacco nicotine transformation, the genes are NtNCP1 and NtNCP2 genes, and the NtNCP1 gene sequence is SEQ ID Shown in No.1, described NtNCP2 gene sequence is shown in SEQ ID No.3.
优选地,对所述NtNCP1基因的序列进行翻译后,其所编码蛋白序列为SEQ ID No.2所示。Preferably, after the sequence of the NtNCP1 gene is translated, its encoded protein sequence is shown in SEQ ID No.2.
优选地,对所述NtNCP2基因的序列进行翻译后,其所编码蛋白序列为SEQ ID No.4所示。Preferably, after the sequence of the NtNCP2 gene is translated, its encoded protein sequence is shown in SEQ ID No.4.
优选地,包括以下步骤:Preferably, the following steps are included:
(1)T0代编辑素材的创制;(1) Creation of T0 generation editing materials;
(2)T0代植株经自交纯合获得纯合编辑素材;(2) Homozygous editing materials were obtained from T0 generation plants through homozygous selfing;
(3)纯合编辑素材种植及性状观察;(3) Planting and trait observation of homozygous edited materials;
(4)以GC-MS进行NtNCP1和NtNCP2基因纯合敲除素材的打顶后14天叶片的生物碱含量的检测,以及烟碱转化率的计算。(4) GC-MS was used to detect the alkaloid content of the leaves of the homozygous knockout material of NtNCP1 and NtNCP2 genes 14 days after topping, and calculate the conversion rate of nicotine.
优选地,步骤(1)中,CRISPR/Cas9系统采用的sgRNA序列为TCATAATGCATATAGGTTGGAGG,所述sgRNA序列采用的引物序列为:Preferably, in step (1), the sgRNA sequence used by the CRISPR/Cas9 system is TCATAATGCATATAGGTTGGAGG, and the primer sequence used by the sgRNA sequence is:
上游引物sgRNA-F:GATTGTCATAATGCATATAGGTTGG;Upstream primer sgRNA-F: GATTGTCATAATGCATATAGGTTGG;
下游引物sgRNA-R:AAACCCCAACCTATATGCATTATGA。Downstream primer sgRNA-R: AAACCCCAACCTATATGCATTATGA.
优选地,步骤(1)中,Preferably, in step (1),
NtNCP1靶点编辑检测采用的引物序列如下:The primer sequences used in NtNCP1 target editing detection are as follows:
上游引物NtNCP1-F:CCATCAGAAGCCACCACCAA;Upstream primer NtNCP1-F: CCATCAGAAGCCACCACCAA;
下游引物NtNCP1-R:TGCTCTGGTTCTTCGGCTAAG;Downstream primer NtNCP1-R: TGCTCTGGTTCTTCGGCTAAG;
NtNCP2靶点编辑检测采用的引物序列如下:The primer sequences used in NtNCP2 target editing detection are as follows:
上游引物NtNCP2-F:CCATCAGAAGCCACCACCAA;Upstream primer NtNCP2-F: CCATCAGAAGCCACCACCAA;
下游引物NtNCP2-R:GCGTTTATTTGCTCCGGTTCTT。Downstream primer NtNCP2-R: GCGTTTATTTGCTCCGGTTCTT.
优选地,步骤(1)具体为:Preferably, step (1) is specifically:
设计sgRNA引导序列,上游引物sgRNA-F和下游引物sgRNA-R退火形成双链,限制性内切酶BsaI-HF酶切CRISPR/Cas9载体pORE-Cas9;将退火形成的双链产物与经酶切好的载体骨架用T4连接酶进行连接;连接产物转化至大肠杆菌感受态细胞,检测获得阳性克隆并提取重组质粒,获得CRISPR-Cas9表达载体;Design the sgRNA guide sequence, the upstream primer sgRNA-F and the downstream primer sgRNA-R anneal to form a double strand, and the restriction endonuclease BsaI-HF digests the CRISPR/Cas9 vector pORE-Cas9; The good vector backbone was ligated with T4 ligase; the ligated product was transformed into E. coli competent cells, positive clones were detected and recombinant plasmids were extracted to obtain CRISPR-Cas9 expression vectors;
将携带CRISPR/Cas9-sgRNA表达载体的农杆菌LBA4404菌液浸泡侵染烟草叶盘,并获得T0代植株,经靶点编辑检测,获得NtNCP1和NtNCP2基因同时发生编辑的植株,收种得到T0代种子。Soak the Agrobacterium LBA4404 carrying the CRISPR/Cas9-sgRNA expression vector to infect tobacco leaf discs, and obtain T0 generation plants. After target editing and detection, the NtNCP1 and NtNCP2 genes are simultaneously edited plants, and the T0 generation is harvested. seed.
步骤(2)具体为:将T0代种子进行自交纯合扩繁种植,经靶点编辑检测,获得NtNCP1和NtNCP2基因发生纯合编辑的植株,收种得到T1代种子,所述NtNCP1和NtNCP2靶点编辑检测采用的引物序列同步骤(1)。Step (2) is specifically as follows: the T0 generation seeds are self-crossed and homozygously multiplied and planted, and the NtNCP1 and NtNCP2 genes are homozygously edited plants are obtained through target editing and detection, and the T1 generation seeds are harvested, and the NtNCP1 and NtNCP2 genes are harvested. The primer sequences used in target editing detection are the same as in step (1).
一种烟草烟碱转化相关的基因在快速制备烟碱转化植株中的应用,所述烟草烟碱转化相关的基因为NtNCP1基因和NtNCP2基因。An application of a gene related to tobacco nicotine conversion in rapidly preparing nicotine-transformed plants, wherein the genes related to tobacco nicotine conversion are NtNCP1 gene and NtNCP2 gene.
一种快速获得栽培烟草烟碱转化株的方法在制备烟草烟碱转化株中的应用。Application of a method for rapidly obtaining and cultivating tobacco nicotine transformed strains in preparing tobacco nicotine transformed strains.
优选地,NtNCP1和NtNCP2基因同时敲除编辑植株打顶后14天的叶片各类生物碱总量与对照植株接近,但烟碱含量极显著低于对照植株,降烟碱含量极显著高于对照植株,烟碱转化率高于20%。Preferably, the total amount of various alkaloids in the leaves of the NtNCP1 and NtNCP2 gene knockout editing plants 14 days after topping is close to that of the control plants, but the nicotine content is extremely significantly lower than that of the control plants, and the nornicotine content is extremely significantly higher than that of the control plants plants, the conversion rate of nicotine is higher than 20%.
本发明上述技术方案,具有如下有益效果:The technical scheme of the present invention has the following beneficial effects:
本发明通过CRISPR/Cas9介导的基因编辑技术,构建了用于同时敲除烟草NtNCP1和NtNCP2基因的CRISPR/Cas9编辑载体,经编辑素材创制和分子检测鉴定后获得了烟草NtNCP1和NtNCP2基因同时敲除的红花大金元编辑植株。The present invention constructs a CRISPR/Cas9 editing vector for simultaneous knockout of tobacco NtNCP1 and NtNCP2 genes through CRISPR/Cas9-mediated gene editing technology, and obtains simultaneous knockout of tobacco NtNCP1 and NtNCP2 genes after creation of editing materials and molecular detection and identification Remove the safflower dajin yuan edited plants.
本发明提供的烟草NtNCP1和NtNCP2基因同时敲除的烟草植株,主要农艺性状与对照(未编辑)相比,株高、腰叶长、腰叶宽、茎围等性状没有明显差异。Compared with the control (unedited), the main agronomic traits of the tobacco plants with simultaneous knockout of the tobacco NtNCP1 and NtNCP2 genes provided by the present invention are not significantly different in traits such as plant height, waist leaf length, waist leaf width, and stem circumference.
本发明提供的烟草烟碱转化相关的基因NtNCP1和NtNCP2,通过气相色谱-质谱联用检测发现,NtNCP1和NtNCP2基因同时敲除编辑植株打顶后14天的叶片各类生物碱总量与对照接近,但烟碱含量极显著低于对照植株,降烟碱含量极显著高于对照,烟碱转化率高于20%。The genes NtNCP1 and NtNCP2 related to the transformation of tobacco nicotine provided by the present invention were detected by gas chromatography-mass spectrometry and found that the total amount of various alkaloids in the leaves of the edited plants 14 days after topping was close to that of the control , but the nicotine content was extremely significantly lower than that of the control plants, the nornicotine content was extremely significantly higher than that of the control plants, and the conversion rate of nicotine was higher than 20%.
综上所述,利用CRISPR/Cas9介导的基因编辑技术敲除同时敲除烟草NtNCP1和NtNCP2基因获得了烟碱含量降低且降烟碱含量增加的编辑素材,这为烟草烟碱转化基因功能研究及烟碱含量调控的烟草新品种定向改良提供遗传材料和理论依据。In summary, the use of CRISPR/Cas9-mediated gene editing technology to knock out and knock out tobacco NtNCP1 and NtNCP2 genes at the same time resulted in edited material with reduced nicotine content and increased nornicotine content, which provides a basis for the study of the function of tobacco nicotine conversion genes. To provide genetic materials and theoretical basis for directional improvement of new tobacco varieties regulated by nicotine content.
附图说明Description of drawings
被结合在说明书中并构成说明书的一部分的附图示出了本发明的实施例,并且连同其说明一起用于解释本发明的原理。The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and together with the description serve to explain the principles of the invention.
图1为本发明的编辑植株与对照(未编辑)主要农艺性状比较。Figure 1 is a comparison of the main agronomic traits of the edited plants of the present invention and the control (unedited).
图2为本发明的编辑植株与对照(未编辑)烟碱转化率比较。Figure 2 is a comparison of the nicotine conversion rate between the edited plants of the present invention and the control (unedited).
具体实施方式Detailed ways
现在将参照附图来详细描述本发明的各种示例性实施例。应注意到:除非另外具体说明,否则在这些实施例中阐述的部件和步骤的相对布置、数字表达式和数值不限制本发明的范围。Various exemplary embodiments of the present invention will now be described in detail with reference to the accompanying drawings. It should be noted that the relative arrangements of components and steps, numerical expressions and numerical values set forth in these embodiments do not limit the scope of the present invention unless specifically stated otherwise.
以下实施例中所有使用的实验方法如无特殊说明,均为常规方法。以下实施例中所用的材料、试剂等,如无特殊说明,均可通过商业途径获得。All the experimental methods used in the following examples are conventional methods unless otherwise specified. The materials and reagents used in the following examples can be obtained through commercial channels unless otherwise specified.
实施例1NtNCP1基因的获得The acquisition of embodiment 1 NtNCP1 gene
以栽培种烟草红花大金元整株为实验材料,利用RNA提取试剂盒提取烟草根部总RNA,反转录为cDNA备用:Using the whole plant of the cultivar Tobacco Safflower Dajinyuan as the experimental material, the total RNA from the root of tobacco was extracted with an RNA extraction kit, and reverse-transcribed into cDNA for future use:
按照植物RNA提取试剂盒说明书提取烟草总RNA。Tobacco total RNA was extracted according to the instructions of the plant RNA extraction kit.
1μg从叶片中提取总RNA用于反转录,转录体系如下:1 μg of total RNA was extracted from leaves for reverse transcription, and the transcription system was as follows:
Total RNA 1μg;Total RNA 1 μg;
Oligo(dT)(10μM) 1.5μL;Oligo(dT)(10μM) 1.5μL;
ddH2O up to 15μL。ddH 2 O up to 15 μL.
将上述体系混匀后置于PCR中,70℃保温5min,去除后立即置于冰上5min,之后向体系中加入以下试剂:Mix the above system and place it in PCR, incubate at 70°C for 5 minutes, immediately place it on ice for 5 minutes after removal, and then add the following reagents to the system:
上述体系放入PCR仪中,42℃65min,65℃10min,4℃保温,之后置于-20℃冰箱中保存使用。The above system was placed in a PCR instrument, kept at 42°C for 65 minutes, 65°C for 10 minutes, kept at 4°C, and then stored in a -20°C refrigerator for use.
通过同源比对的方法,参考已知烟草部分基因序列,设计扩增引物序列如下:Through the method of homology comparison, refer to the known partial gene sequence of tobacco, and design the amplification primer sequence as follows:
F:5’-ATGGCGTCAAAGCTCTTTTTGG-3’(SEQ ID No.5);F: 5'-ATGGCGTCAAAGCTCTTTTTGG-3' (SEQ ID No.5);
R:5’-TCAAAAATAATCAACTACAGGAG-3’(SEQ ID No.6)。R: 5'-TCAAAAATAATCAACTACAGGAG-3' (SEQ ID No. 6).
以上述所制备cDNA为模板,利用上述引物进行PCR扩增:Using the cDNA prepared above as a template, PCR amplification was performed using the above primers:
扩增体系(50μL):Amplification system (50μL):
混匀离心后进行PCR扩增,PCR反应条件为:95℃10sec,52℃30sec,72℃2min,共30个循环;72℃10min;25℃Hold。After mixing and centrifuging, perform PCR amplification. The PCR reaction conditions are: 95°C for 10 sec, 52°C for 30 sec, 72°C for 2 min, a total of 30 cycles; 72°C for 10 min; 25°C Hold.
对扩增产物进行提纯后测序,获得烟草烟碱转化相关的基因NtNCP1序列,其碱基序列如SEQ ID No.1所示,共包括690个碱基。对该基因序列进行翻译后,其所编码蛋白序列如SEQ ID No.2所示,共包括229个氨基酸残基。The amplified product was purified and then sequenced to obtain the sequence of the gene NtNCP1 related to tobacco nicotine conversion, whose base sequence is shown in SEQ ID No.1, including a total of 690 bases. After the gene sequence is translated, the encoded protein sequence is shown in SEQ ID No. 2, including a total of 229 amino acid residues.
实施例2NtNCP2基因的获得The acquisition of embodiment 2NtNCP2 gene
以栽培种烟草红花大金元整株为实验材料,利用RNA提取试剂盒提取烟草根部总RNA,反转录为cDNA备用:Using the whole plant of the cultivar Tobacco Safflower Dajinyuan as the experimental material, the total RNA from the root of tobacco was extracted with an RNA extraction kit, and reverse-transcribed into cDNA for future use:
按照植物RNA提取试剂盒说明书提取烟草总RNA。Tobacco total RNA was extracted according to the instructions of the plant RNA extraction kit.
1μg从叶片中提取总RNA用于反转录,转录体系如下:1 μg of total RNA was extracted from leaves for reverse transcription, and the transcription system was as follows:
Total RNA 1μg;Total RNA 1 μg;
Oligo(dT)(10μM) 1.5μL;Oligo(dT)(10μM) 1.5μL;
ddH2O up to 15μL。ddH 2 O up to 15 μL.
将上述体系混匀后置于PCR中,70℃保温5min,去除后立即置于冰上5min,之后向体系中加入以下试剂:Mix the above system and place it in PCR, incubate at 70°C for 5 minutes, immediately place it on ice for 5 minutes after removal, and then add the following reagents to the system:
上述体系放入PCR仪中,42℃65min,65℃10min,4℃保温,之后置于-20℃冰箱中保存使用。The above system was placed in a PCR instrument, kept at 42°C for 65 minutes, 65°C for 10 minutes, kept at 4°C, and then stored in a -20°C refrigerator for use.
通过同源比对的方法,参考已知烟草部分基因序列,设计扩增引物序列如下:Through the method of homology comparison, refer to the known partial gene sequence of tobacco, and design the amplification primer sequence as follows:
F:5’-ATGGCCCAATGTATGGATGCTG-3’(SEQ ID No.7);F: 5'-ATGGCCCAATGTATGGATGCTG-3' (SEQ ID No. 7);
R:5’-TCAAAAATAATCAATTACAGGAG-3’(SEQ ID No.8)。R: 5'-TCAAAAATAATCAATTACAGGAG-3' (SEQ ID No. 8).
以上述所制备cDNA为模板,利用上述引物进行PCR扩增:Using the cDNA prepared above as a template, PCR amplification was performed using the above primers:
扩增体系(50μL):Amplification system (50μL):
混匀离心后进行PCR扩增,PCR反应条件为:95℃10sec,52℃30sec,72℃2min,共30个循环;72℃10min;25℃Hold。After mixing and centrifuging, perform PCR amplification. The PCR reaction conditions are: 95°C for 10 sec, 52°C for 30 sec, 72°C for 2 min, a total of 30 cycles; 72°C for 10 min; 25°C Hold.
对扩增产物进行提纯后测序,获得烟草烟碱转化相关的基因NtNCP2序列,其碱基序列如SEQ ID No.3所示,共包括1083个碱基。对该基因序列进行翻译后,其所编码蛋白序列如SEQ ID No.4所示,共包括360个氨基酸残基。The amplified product was purified and then sequenced to obtain the sequence of NtNCP2, a gene related to tobacco nicotine conversion, whose base sequence is shown in SEQ ID No.3, including a total of 1083 bases. After the gene sequence is translated, the encoded protein sequence is shown in SEQ ID No.4, including a total of 360 amino acid residues.
实施例3表达载体的构建The construction of embodiment 3 expression vector
利用实施例1中所获得烟碱转化相关的基因NtNCP1和NtNCP2,本发明进一步构建了CRISPR/Cas9载体。Using the genes NtNCP1 and NtNCP2 related to nicotine conversion obtained in Example 1, the present invention further constructed a CRISPR/Cas9 vector.
(1)NtNCP1和NtNCP2基因的sgRNA序列的设计和合成:(1) Design and synthesis of sgRNA sequences of NtNCP1 and NtNCP2 genes:
利用在线软件CRISPR-P 2.0(http://cbi.hzau.edu.cn/crispr/)设计sgRNA引导序列,选择分值较高且位于NtNCP1和NtNCP2基因序列合适位置的引导序列。本申请选择的sgRNA序列为:TCATAATGCATATAGGTTGGAGG(SEQ ID No.9)。The sgRNA guide sequence was designed using the online software CRISPR-P 2.0 (http://cbi.hzau.edu.cn/crispr/), and the guide sequence with a higher score and located at the appropriate position of the NtNCP1 and NtNCP2 gene sequences was selected. The sgRNA sequence selected in this application is: TCATAATGCATATAGGTTGGAGG (SEQ ID No.9).
(2)设计sgRNA序列的正反引物并交由设计公司合成:(2) Design the forward and reverse primers of the sgRNA sequence and submit them to the design company for synthesis:
上游引物sgRNA-F:GATTGTCATAATGCATATAGGTTGG(SEQ ID No.10);Upstream primer sgRNA-F: GATTGTCATAATGCATATAGGTTGG (SEQ ID No.10);
下游引物sgRNA-R:AAACCCCAACCTATATGCATTATGA(SEQ ID No.11)。Downstream primer sgRNA-R: AAACCCCAACCTATATGCATTATGA (SEQ ID No.11).
(3)引物退火:将合成的靶序列引物(上游引物和下游引物)用灭菌ddH2O稀释成浓度为100ng/μL,而后,上下游引物各取5μL至PCR管中混合均匀,置于PCR仪上进行退火,使上下游Oligo单链经退火形成双链。(3) Primer annealing: Dilute the synthesized target sequence primers (upstream primer and downstream primer) with sterilized ddH 2 O to a concentration of 100 ng/μL, then take 5 μL of each of the upstream and downstream primers and mix them evenly in a PCR tube, place in Annealing is carried out on the PCR instrument, so that the upstream and downstream Oligo single strands are annealed to form double strands.
PCR仪退火程序为:95℃2min,-0.1℃/8s,退火至25℃,退火产物加入90μL无菌水稀释成10ng/μL。The annealing program of the PCR instrument is: 95°C for 2min, -0.1°C/8s, annealed to 25°C, and the annealed product was diluted to 10 ng/µL by adding 90 μL of sterile water.
(4)酶切与连接(4) Digestion and connection
a.用限制性内切酶BsaI-HF酶切CRISPR/Cas9载体pORE-Cas9(由西南大学提供)。a. Digest the CRISPR/Cas9 vector pORE-Cas9 (provided by Southwest University) with restriction endonuclease BsaI-HF.
酶切体系(50μL):Enzyme digestion system (50μL):
37℃过夜酶切,经1.5%琼脂糖凝胶电泳,切割目的片段条带,用胶回收试剂盒回收骨架片段。Enzyme digestion at 37°C overnight, followed by 1.5% agarose gel electrophoresis to cut the target fragment band, and recover the backbone fragment with a gel extraction kit.
b.连接b. to connect
将退火形成的双链产物与经酶切好的载体骨架进行连接。The double-stranded product formed by annealing is ligated to the backbone of the digested carrier.
连接体系(10μL):Ligation System (10μL):
连接条件为:16℃连接2小时。The connection conditions are: 16°C for 2 hours.
(5)转化大肠杆菌:(5) transform Escherichia coli:
a.从-80℃取出Trans-T1感受态细胞置于冰上冻融,分成50μL/份;a. Take out Trans-T1 competent cells from -80°C, freeze and thaw on ice, and divide into 50 μL/portion;
b.待感受态细胞融化后,将10μL连接产物加入感受态中,轻轻混匀,冰浴10min;b. After the competent cells are thawed, add 10 μL of the ligation product to the competent cells, mix gently, and bathe in ice for 10 minutes;
c.冰浴后,置于42℃水浴锅中热激90s,迅速将感受态放回冰上静置2min。c. After ice-bathing, heat-shock in a 42°C water bath for 90 seconds, and quickly put the competent cells back on ice for 2 minutes.
d.将60μL转化产物均匀涂布于含有16mg/L卡那霉素LB固体培养基中,于37℃细菌培养箱中培养12小时。d. Evenly spread 60 μL of the transformation product on LB solid medium containing 16 mg/L kanamycin, and incubate in a bacterial incubator at 37° C. for 12 hours.
(6)阳性克隆筛选:(6) Positive clone screening:
a.待平板长出单克隆,挑取大肠杆菌单克隆到含有50mg/L的卡那霉素LB液体培养基中,于37℃摇床过夜摇混;a. After a single colony grows on the plate, pick a single colony of E. coli into LB liquid medium containing 50 mg/L kanamycin, and shake it overnight on a shaker at 37°C;
b.取部分菌液进行菌液PCR,经核酸电泳检测是否为阳性克隆;b. Take part of the bacterial liquid for bacterial liquid PCR, and check whether it is a positive clone by nucleic acid electrophoresis;
c.将初步检测为阳性克隆的菌液余下部分提取大肠杆菌质粒。送质粒至诺禾致源公司进行测序,确认阳性克隆的正确性。c. Escherichia coli plasmids were extracted from the remaining part of the bacterial solution initially detected as positive clones. Send the plasmid to Novogene for sequencing to confirm the correctness of the positive clone.
实施例4T0代植株的获得及检测The acquisition and detection of the T0 generation plant of embodiment 4
(1)转化农杆菌(1) Transformation of Agrobacterium
利用上一步所构建的CRISPR/Cas9-NtNCP1-NtNCP2编辑载体质粒,以红花大金元为例,进行遗传转化和组培,获得烟草烟碱转化相关的基因NtNCP1和NtNCP2发生敲除编辑的植株,相关实验过程简要介绍如下。Using the CRISPR/Cas9-NtNCP1-NtNCP2 editing vector plasmid constructed in the previous step, taking Honghua Dajinyuan as an example, carry out genetic transformation and tissue culture, and obtain plants with knockout and edited genes NtNCP1 and NtNCP2 related to tobacco nicotine transformation , and the related experimental procedures are briefly introduced as follows.
将烟草种子表面消毒后点种至MS培养基上,待长到4片子叶(15-20d),移入含MS固体培养基的培养瓶中,于25±1℃、光照强度30-50μmol/(m2·s),光照时间为16h/d条件继续培养35-40d,备用。Sterilize the surface of the tobacco seeds and plant them on the MS medium. After they grow to 4 cotyledons (15-20 days), transfer them into a culture bottle containing MS solid medium, and place them at 25±1°C with a light intensity of 30-50 μmol/( m 2 ·s), the light time is 16h/d, and the culture is continued for 35-40d, and it is set aside.
将正确序列的质粒转化农杆菌,具体步骤如下:Transform the plasmid with the correct sequence into Agrobacterium, the specific steps are as follows:
①取出-80℃保存的LBA4404电转化感受态农杆菌细胞,置于冰上冻融。① Take out the LBA4404 electroporation-competent Agrobacterium cells stored at -80°C, and freeze-thaw them on ice.
②待感受态刚刚解冻时,加入CRISPR/Cas9-NtNCP1-NtNCP2编辑载体质粒的2μL,混匀,置于冰上。②When the competent cells are just thawed, add 2 μL of the CRISPR/Cas9-NtNCP1-NtNCP2 editing vector plasmid, mix well, and place on ice.
③将混匀的感受态转移至预冷的电转杯中,将电转杯置于电转仪中进行转化,转化完成后加入1mL的YEB液体培养基与转化液进行混合,后置于摇床28℃,200rpm培养1.5-2h。③Transfer the mixed competent state to a pre-cooled electric transfer cup, place the electric transfer cup in the electrotransfer instrument for transformation, add 1mL of YEB liquid medium to mix with the transformation solution after the transformation is completed, and then place it on a shaker at 28°C , 200rpm for 1.5-2h.
④培养基在8,000rpm离心,弃上清,再用200μL的YEB液体培养基悬浮菌体,涂于含50mg/L利福平、50mg/L链霉素和50mg/L卡那霉素的YEB固体培养基上28℃倒置黑暗培养2-3d。④Centrifuge the culture medium at 8,000rpm, discard the supernatant, then suspend the bacteria with 200μL of YEB liquid medium, and apply to YEB containing 50mg/L rifampicin, 50mg/L streptomycin and 50mg/L kanamycin Incubate in the dark at 28°C for 2-3 days on solid medium.
(2)侵染愈伤组织(2) Infect callus
①在超净工作台中制作烟草叶盘成边长为1cm的方形叶盘,用MS液体制备含有CRISPR/Cas9-NtNCP1-NtNCP2编辑载体的农杆菌菌落成悬浮菌液(OD600=0.6-0.8)。①Make tobacco leaf discs with a side length of 1cm in the ultra-clean workbench, and use MS liquid to prepare the Agrobacterium colony suspension containing the CRISPR/Cas9-NtNCP1-NtNCP2 editing vector (OD 600 =0.6-0.8) .
②利用悬浮农杆菌菌液浸泡侵染烟草叶盘10min。② Soak and infect tobacco leaf discs with suspended Agrobacterium liquid for 10 minutes.
③将叶盘置于含2.0mg/L NAA+0.5mg/L 6-BA的MS固体培养基上,28℃,黑暗,共培养3d。③Put leaf discs on MS solid medium containing 2.0mg/L NAA+0.5mg/L 6-BA, co-cultivate for 3 days at 28°C in the dark.
④进行继代培养,放置于含2.0mg/L NAA+0.5mg/L 6-BA+250mg/LCb+50mg/L Kan的MS固体培养基上。④ For subculture, place on MS solid medium containing 2.0mg/L NAA+0.5mg/L 6-BA+250mg/LCb+50mg/L Kan.
培养条件为:28℃光照培养16h/d,光照强度30-50μmol/(m2·s),25℃黑暗培养8h/d,培养45-60d,直至分化芽形成,每7-10d更换一次分化培养培养基,更换3-4次;培养至分化芽形成;将已有分化芽形成的愈伤组织切下,置于含有500mg/L羧苄青霉素与50mg/L卡那霉素的MS培养基上进行培养,待愈伤组织上分化芽培养长至2-4cm高,培养条件与分化培养条件一致,培养8-14d;再生植株生根培养,将分化芽切下,插入含有500mg/L羧苄青霉素与50mg/L卡那霉素的MS培养基上进行生根培养,培养条件与分化培养条件一致,培养20-30d,再生移栽至花盆后进行培养,后进行转化植株叶片取样,送华大基因进行分子检测,NtNCP1靶点检测引物为:上游引物NtNCP1-F:CCATCAGAAGCCACCACCAA(SEQ ID No.12)和下游引物NtNCP1-R:TGCTCTGGTTCTTCGGCTAAG(SEQ ID No.13);NtNCP2靶点检测引物为:上游引物NtNCP2-F:CCATCAGAAGCCACCACCAA(SEQ ID No.14)和下游引物NtNCP2-R:GCGTTTATTTGCTCCGGTTCTT(SEQ ID No.15),确定获得NtNCP1和NtNCP2基因同时敲除的T0代植株,收种备用。The culture conditions are: light culture at 28°C for 16h/d, light intensity 30-50μmol/(m2 s), dark culture at 25°C for 8h/d, culture for 45-60d, until the formation of differentiated buds, replace the differentiation culture every 7-10d Replace the medium for 3-4 times; culture until the formation of differentiated shoots; excise the calli that have formed differentiated shoots, and place them on MS medium containing 500mg/L carbenicillin and 50mg/L kanamycin Carry out culture, until the differentiated shoots on the callus grow to 2-4cm high, the culture conditions are consistent with the differentiation culture conditions, and cultivate for 8-14d; the regenerated plants are rooted and cultured, the differentiated shoots are cut off, and inserted with 500mg/L carbenicillin Rooting culture was carried out on MS medium with 50mg/L kanamycin, the culture conditions were consistent with the differentiation culture conditions, cultured for 20-30 days, regenerated and transplanted to flowerpots for cultivation, and then transformed plant leaves were sampled and sent to Huada University For molecular detection of the gene, the NtNCP1 target detection primers are: upstream primer NtNCP1-F: CCATCAGAAGCCACCACCAA (SEQ ID No.12) and downstream primer NtNCP1-R: TGCTCTGGTTCTTCGGCTAAG (SEQ ID No.13); NtNCP2 target detection primer is: upstream Primer NtNCP2-F: CCATCAGAAGCCACCACCAA (SEQ ID No. 14) and downstream primer NtNCP2-R: GCGTTTATTTGCTCCGGTTCTT (SEQ ID No. 15) were determined to obtain T0 generation plants with simultaneous knockout of NtNCP1 and NtNCP2 genes, and harvested for later use.
实施例5纯合编辑素材的获得Embodiment 5 Obtaining of Homozygous Editing Materials
T0代种子按96倍进行自交纯合扩繁,待植株长到5-6片叶时,单株的叶片取样,送华大基因进行分子检测NtNCP1靶点检测引物为:上游引物NtNCP1-F:CCATCAGAAGCCACCACCAA(SEQ ID No.12)和下游引物NtNCP1-R:TGCTCTGGTTCTTCGGCTAAG(SEQ ID No.13);NtNCP2靶点检测引物为:上游引物NtNCP2-F:CCATCAGAAGCCACCACCAA(SEQID No.14)和下游引物NtNCP2-R:GCGTTTATTTGCTCCGGTTCTT(SEQ ID No.15),确定获得NtNCP1和NtNCP2基因发生纯合编辑的植株,之后进行收种获得NtNCP1和NtNCP2基因纯合编辑的T1代种子。The seeds of the T0 generation are self-crossed and homozygous at a rate of 96 times. When the plants grow to 5-6 leaves, the leaves of a single plant are sampled and sent to Huada Gene for molecular detection. The primers for NtNCP1 target detection are: upstream primer NtNCP1-F : CCATCAGAAGCCACCACCAA (SEQ ID No.12) and downstream primer NtNCP1-R: TGCTCTGGTTCTTCGGCTAAG (SEQ ID No.13); NtNCP2 target detection primers are: upstream primer NtNCP2-F: CCATCAGAAGCCACCACCAA (SEQ ID No.14) and downstream primer NtNCP2- R: GCGTTTATTTGCTCCGGTTCTT (SEQ ID No.15), determine the homozygous edited plants of NtNCP1 and NtNCP2 genes, and then harvest the T1 generation seeds of homozygous edited NtNCP1 and NtNCP2 genes.
实施例6素材种植及性状调查Embodiment 6 material planting and character investigation
利用实施例4中分子检测确定为NtNCP1和NtNCP2基因纯合敲除的植株种子以盆栽方式进行扩繁种植,种植60株,盛花期打顶,打顶后10天参考《YCT 142-2010烟草农艺性状调查测量方法》,测定分析株高、腰叶长、腰叶宽、茎围、节距等性状指标。The seeds of the plants whose NtNCP1 and NtNCP2 gene homozygous knockouts were identified by molecular detection in Example 4 were propagated and planted in a potted manner, and 60 plants were planted, topped at the full flowering stage, and 10 days after topping, refer to "YCT 142-2010 Tobacco Agronomy" Traits Investigation and Measurement Method”, measuring and analyzing traits such as plant height, waist leaf length, waist leaf width, stem girth, and pitch.
现在打顶后10天的烟株,采集10株烟株的株高、腰叶长、腰叶宽、茎围等指标数据,并进行统计分析。Now for the tobacco plants 10 days after topping, collect index data such as plant height, waist leaf length, waist leaf width, stem circumference and other index data of 10 tobacco strains, and carry out statistical analysis.
结果表明,NtNCP1和NtNCP2基因同时敲除的植株的株高、茎围、腰叶长、腰叶宽等指标与对照接近,没有明显差异。对照和NtNCP1和NtNCP2基因纯合编辑烟草植株的主要性状对比如图1所示。The results showed that the plant height, stem girth, waist leaf length, waist leaf width and other indicators of the NtNCP1 and NtNCP2 gene knockout plants were close to those of the control without significant difference. The comparison of the main traits of the control and NtNCP1 and NtNCP2 gene homozygous edited tobacco plants is shown in Figure 1.
实施例7GC-MS检测Embodiment 7GC-MS detects
利用实施例5中种植的编辑植株,随后以GC-MS进行NtNCP1和NtNCP2基因纯合敲除素材的打顶后14天叶片的生物碱含量的检测试验。Using the edited plants planted in Example 5, GC-MS was used to detect the alkaloid content of the leaves 14 days after topping of the NtNCP1 and NtNCP2 gene homozygous knockout materials.
选择打顶后14天的烟株,采集5株对照(未编辑)烟草植株样本,采集同一叶位的叶片;选择打顶后10天的烟株,采集5株NtNCP1和NtNCP2基因纯合编辑的烟草植株样本;叶片去主筋,锡箔纸包裹液氮保存运输,实验室超低温(-70℃)保存,冻干磨粉过筛。Tobacco plants 14 days after topping were selected, and 5 control (unedited) tobacco plant samples were collected, and leaves at the same leaf position were collected; tobacco plants 10 days after topping were selected, and 5 plants homozygously edited for NtNCP1 and NtNCP2 genes were collected. Tobacco plant samples; the main tendons are removed from the leaves, wrapped in tin foil paper for storage and transportation, stored at ultra-low temperature (-70°C) in the laboratory, freeze-dried, ground and sieved.
称取0.2g样品于15mL离心管,精确至0.1mg,加入2.0mL5%氢氧化钠溶液,再分别加入0.05mL内标溶液A(二甲基喹啉溶液,甲醇配制,二氯甲烷稀释到1.0mg/mL)和内标溶液B(2,2’-联吡啶-d2溶液,甲醇配制,二氯甲烷稀释到0.5mg/mL),振荡混匀后,静置20min,然后加入10.0mL萃取溶液(二氯甲烷和甲醇按照体积比4:1混匀),加盖密封后至于涡旋振荡器中,以2000r/min的速度振荡提取40min,静置1h后,离心8min,取下层有机相转移到色谱瓶中,上GC-MS进行分析。Weigh 0.2g of sample into a 15mL centrifuge tube, accurate to 0.1mg, add 2.0mL of 5% sodium hydroxide solution, and then add 0.05mL of internal standard solution A (dimethylquinoline solution, prepared in methanol, dilute to 1.0 mg/mL) and internal standard solution B (2,2'-bipyridyl-d2 solution, prepared in methanol, diluted to 0.5mg/mL with dichloromethane), shake and mix well, let stand for 20min, and then add 10.0mL extraction solution (dichloromethane and methanol are mixed according to the volume ratio of 4:1), put the cover and seal it into the vortex shaker, shake and extract at a speed of 2000r/min for 40min, after standing for 1h, centrifuge for 8min, take the lower organic phase and transfer into a chromatographic vial for analysis by GC-MS.
气相色谱参考条件为:色谱柱:DB-35MS或等同柱效毛细管色谱柱,规格为:30mm(长度)×0.25mm(内径)×0.25m(膜厚);进样口温度:250℃;柱流量:1.0mL/min;烟碱进样体积:1.0L,分流进样,分流比为40:1;其它生物碱进样体积:2.0L,分流进样,分流比为10:1;升温程序:初始温度100℃,保持3min;以8℃/min的速率上升至260℃,保持10min。The reference conditions of gas chromatography are: chromatographic column: DB-35MS or equivalent column efficiency capillary chromatographic column, specifications: 30mm (length) × 0.25mm (inner diameter) × 0.25m (film thickness); inlet temperature: 250°C; column Flow rate: 1.0mL/min; nicotine injection volume: 1.0L, split injection, split ratio 40:1; other alkaloid injection volume: 2.0L, split injection, split ratio 10:1; heating program : Initial temperature is 100°C, keep for 3min; increase to 260°C at a rate of 8°C/min, keep for 10min.
质谱参考条件:传输线温度:280℃;电离方式:电子轰击源(EI);电离能量:70eV;离子源温度:230℃;溶剂延迟:8min;测定方式:选择离子监测方式(SIM)扫描。Mass spectrometry reference conditions: transfer line temperature: 280°C; ionization method: electron impact source (EI); ionization energy: 70eV; ion source temperature: 230°C; solvent delay: 8min; measurement method: selected ion monitoring (SIM) scanning.
对照(未编辑)及NtNCP1和NtNCP2基因纯合编辑烟草植株打顶后14天叶片烟碱含量比较(结果如表1所示),结果表明:通过气相色谱-质谱(GC-MS)联用检测发现,NtNCP1和NtNCP2基因敲除编辑植株打顶后14生物碱总量与对照接近,但烟碱含量极显著低于对照植株,降烟碱含量极显著高于对照,烟碱转化率24.3%(对照为0.5%),超过2.5%的判定标准,表明通过基因编辑同时敲除栽培烟草NtNCP1和NtNCP2基因可快速获得烟碱转化株。这为烟草烟碱转化相关基因功能研究以及烟碱含量调控烟草新品种培育提供了遗传材料和理论依据。Comparison of nicotine content in leaves of control (unedited) and NtNCP1 and NtNCP2 gene homozygous edited tobacco plants 14 days after topping (results are shown in Table 1). It was found that the total amount of 14 alkaloids in the NtNCP1 and NtNCP2 gene knockout edited plants was close to that of the control, but the nicotine content was significantly lower than that of the control plants, the nornicotine content was significantly higher than that of the control plants, and the nicotine conversion rate was 24.3% ( The control is 0.5%), exceeding the criterion of 2.5%, indicating that the nicotine transformed strain can be rapidly obtained by knocking out the NtNCP1 and NtNCP2 genes of the cultivated tobacco simultaneously by gene editing. This provides genetic material and theoretical basis for the research on the function of genes related to tobacco nicotine conversion and the cultivation of new tobacco varieties regulated by nicotine content.
表1为本发明的编辑植株与对照(未编辑)打顶后14天新鲜烟叶生物碱含量(μg/g)Table 1 shows the alkaloid content (μg/g) of the edited plants of the present invention and the control (unedited) fresh tobacco leaves 14 days after topping
虽然本发明已以实施例公开如上,然其并非用于限定本发明,任何本领域技术人员,在不脱离本发明的精神和范围内,均可作各种不同的选择和修改,因此本发明的保护范围由权利要求书及其等同形式所限定。Although the present invention has been disclosed as above with the embodiments, it is not intended to limit the present invention, and any person skilled in the art can make various choices and modifications without departing from the spirit and scope of the present invention. Therefore, the present invention The scope of protection is defined by the claims and their equivalents.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310004201.8A CN115896168B (en) | 2023-01-03 | 2023-01-03 | A method for rapidly obtaining nicotine-converted strains of cultivated tobacco and its application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310004201.8A CN115896168B (en) | 2023-01-03 | 2023-01-03 | A method for rapidly obtaining nicotine-converted strains of cultivated tobacco and its application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115896168A true CN115896168A (en) | 2023-04-04 |
| CN115896168B CN115896168B (en) | 2025-02-11 |
Family
ID=86488259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310004201.8A Active CN115896168B (en) | 2023-01-03 | 2023-01-03 | A method for rapidly obtaining nicotine-converted strains of cultivated tobacco and its application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115896168B (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008212065A (en) * | 2007-03-05 | 2008-09-18 | Japan Tobacco Inc | Gene having function of regulating alkaloid content, and transformed nicotiana plant utilizing the gene |
| US20200140875A1 (en) * | 2017-05-31 | 2020-05-07 | 22Nd Century Limited, Llc | Genome editing methods for producing low-nicotine tobacco products |
| CN113980978A (en) * | 2021-11-22 | 2022-01-28 | 云南中烟工业有限责任公司 | Tobacco nicotine transport protein related gene and application thereof |
| CN114410677A (en) * | 2021-11-22 | 2022-04-29 | 云南中烟工业有限责任公司 | A method and application of CRISPR/Cas9 knockout NtBBLs to create low-nicotine tobacco mutants |
-
2023
- 2023-01-03 CN CN202310004201.8A patent/CN115896168B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008212065A (en) * | 2007-03-05 | 2008-09-18 | Japan Tobacco Inc | Gene having function of regulating alkaloid content, and transformed nicotiana plant utilizing the gene |
| US20200140875A1 (en) * | 2017-05-31 | 2020-05-07 | 22Nd Century Limited, Llc | Genome editing methods for producing low-nicotine tobacco products |
| CN113980978A (en) * | 2021-11-22 | 2022-01-28 | 云南中烟工业有限责任公司 | Tobacco nicotine transport protein related gene and application thereof |
| CN114410677A (en) * | 2021-11-22 | 2022-04-29 | 云南中烟工业有限责任公司 | A method and application of CRISPR/Cas9 knockout NtBBLs to create low-nicotine tobacco mutants |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115896168B (en) | 2025-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105063061B (en) | A kind of rice mass of 1000 kernel gene tgw6 mutant and the preparation method and application thereof | |
| CN113999857B (en) | Gene related to synthesis regulation of nicotine in tobacco and application thereof | |
| BR112017003842B1 (en) | METHOD FOR PRODUCING A TOBACCO PRODUCT | |
| CN113980978B (en) | Tobacco nicotine transporter related gene and application thereof | |
| CN115960849A (en) | Rice heading stage related gene OsJMJ718 and application of encoding protein thereof | |
| CN105063026A (en) | Rice thousand kernel weight gene TGW6 guided RNA target sequence and application thereof | |
| WO2025145606A1 (en) | Use of overexpression of auxin transporter ptopin1a gene in increasing biomass of populus tomentosa | |
| CN115896128A (en) | A tobacco nitrate transporter NtNPF6.13, its coding gene and its application | |
| CN116217685A (en) | A method and application of knocking out tobacco NtLNP1 gene to obtain tobacco with leaf shape change and low nicotine content | |
| CN118773213B (en) | Application of gene NtSULTR3.4 related to nicotine metabolism and plant height regulation of tobacco in nicotine metabolism and plant height regulation | |
| CN114836430B (en) | Application of a tobacco ABA receptor protein gene NtPYL6 in regulating tobacco plant height and rutin content in leaves | |
| CN111187777B (en) | Application of soybean GmTST2.1 gene in soybean breeding | |
| WO2018119124A1 (en) | Compositions and methods for producing tobacco plants and products having altered alkaloid levels | |
| CN118374546A (en) | Application of BnaA08.PSK1 gene in regulating fatty acid composition of rapeseed | |
| CN115896168A (en) | A method and application of rapidly obtaining and cultivating tobacco nicotine transformed strains | |
| CN114410677A (en) | A method and application of CRISPR/Cas9 knockout NtBBLs to create low-nicotine tobacco mutants | |
| CN114438105B (en) | A kind of tobacco NtMLO6-1 gene and its knockout method and application | |
| CN109640707B (en) | Process for the production of dried tobacco material | |
| CN118207252A (en) | Application and method of knock-out populus tomentosa PtoTCP gene in improving lodging resistance of plants | |
| CN114085845B (en) | Tobacco nicotine metabolism related gene and application thereof | |
| CN116120417A (en) | A kind of tobacco chloroplast-associated protein gene NtTHF1 and its application | |
| CN116286710A (en) | A kind of tobacco xyloglucan endoglucosylase/hydrolase protein gene NtXTH8 and its application | |
| CN116064588A (en) | Tobacco auxin response transcription factor ARF2 related gene and application thereof | |
| CN114507688A (en) | Application of tobacco NtCNGC4 gene in preparation of tobacco mutant material for regulating plant height and leaf amino acid content | |
| CN114591979B (en) | A tobacco ubiquitin conjugating enzyme NtE2 gene and its application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |